Detalhe da pesquisa
1.
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Int J Cancer
; 147(5): 1334-1342, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022259
2.
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
Br J Cancer
; 117(2): 164-170, 2017 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28641315
3.
Real-world management practices and characteristics of patients with advanced melanoma initiated on immuno-oncology or targeted therapy in the first-line setting during the period 2015-2018 in Greece. The 'SUMMER' study: a retrospective multicenter chart review project.
Melanoma Res
; 34(2): 152-165, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092014
4.
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
PLoS One
; 18(11): e0294382, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943834
5.
Objective Response to First-Line Treatment as a Predictor of Overall Survival in Metastatic Breast Cancer: A Retrospective Analysis from Two Centers over a 25-Year Period.
Breast Care (Basel)
; 17(3): 264-271, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35949417
6.
Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
PLoS One
; 16(6): e0252537, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34061904
7.
Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study.
Transl Lung Cancer Res
; 10(8): 3538-3549, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584855
8.
Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy.
Cancers (Basel)
; 12(5)2020 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438598
9.
Brain and bone marrow metastases from rectal cancer.
Ann Gastroenterol
; 33(1): 95-97, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892804
10.
Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
Ann Surg Oncol
; 15(4): 1183-92, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18239973
11.
Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
Clin Breast Cancer
; 18(1): 88-94, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153775
12.
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
Int J Radiat Oncol Biol Phys
; 56(5): 1284-7, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12873672
13.
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung Cancer
; 44(3): 363-8, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15140550
14.
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Anticancer Res
; 24(6): 4217-21, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15736475